Potential risks and benefits of nanotechnology: perceptions of risk in sunscreens

Paul FA Wright
Med J Aust 2016; 204 (10): 369-370. || doi: 10.5694/mja15.01128
Published online: 6 June 2016

The available evidence indicates that nanoparticle sunscreens are both effective and safe

The applications for engineered nanomaterials and nanotechnology are developing exponentially, along with the awareness in government, industry and public groups of nanosafety issues. There is also growing public concern caused by negative perceptions among some high profile groups that nano-enabled products are proliferating uncontrollably and being released without adequate testing of their safety.1

What are the potential risks?

In reality, a one-size-fits-all approach to evaluating the potential risks and benefits of nanotechnology for human health is not possible because it is both impractical and would be misguided. There are many types of engineered nanomaterials, and not all are alike or potential hazards. Many factors should be considered when evaluating the potential risks associated with an engineered nanomaterial: the likelihood of being exposed to nanoparticles (ranging in size from 1 to 100 nanometres, about one-thousandth of the width of a human hair) that may be shed by the nanomaterial; whether there are any hotspots of potential exposure to shed nanoparticles over the whole of the nanomaterial’s life cycle; identifying who or what may be exposed; the eventual fate of the shed nanoparticles; and whether there is a likelihood of adverse biological effects arising from these exposure scenarios.1

The intrinsic toxic properties of compounds contained in the nanoparticle are also important, as well as particle size, shape, surface charge and physico-chemical characteristics, as these greatly influence their uptake by cells and the potential for subsequent biological effects. In summary, nanoparticles are more likely to have higher toxicity than bulk material if they are insoluble, penetrate biological membranes, persist in the body, or (where exposure is by inhalation) are long and fibre-like.1 Ideally, nanomaterial development should incorporate a safety-by-design approach, as there is a marketing edge for nano-enabled products with a reduced potential impact on health and the environment.1

What are the potential benefits?

Numerous prospective benefits for health and the environment are offered by nanotechnology, with engineered nanomaterials being developed for renewable energy capture and battery storage, water purification, food packaging, environmental sensors and remediation, as well as greener engineering and manufacturing processes. Some examples of the latter include highly efficient, low energy lighting sources, and smart clothing including a layer of piezo-electric crystals in nanomaterials for powering the wearer’s electronic devices.

The field of nanomedicine has also rapidly progressed from specialised drug delivery applications deploying liposomes (while many are not strictly nanoparticle-sized by international standard definitions, they can be engineered at the nano-scale) to nanoshells and transdermal patches, as well as the development of biocompatible nanomaterial prosthetic implants, and the metal-containing functionalised nanoparticles used for both the imaging and treatment of various cancers. Nanotechnology is also being used to develop point-of-care internet-linked diagnostic devices (eg, “doctor-on-a-chip” diagnostic tools). Nanobionics has made advances in solving the problems of interfacing between medical devices or bionic prosthetics and the nervous system;2 for example, invasive cranial sensing electrodes made of traditional cytotoxic metals are being replaced by more biocompatible surface transistors that can also be coupled with a dosing device.

Some common nano-enabled products currently available contain silver nanoparticles for their antimicrobial effects,3 including clothing items that require less frequent washing. This was mainly because of the ease of incorporating nanosilver into the surface of such products, but the quality of these products has unfortunately been variable, with some rapidly leaching silver ions. Nanosilver should preferably be reserved for more important applications, such as medical dressings for treating resistant infections that impair wound healing.3

Risk perception and weighing up the risks and benefits

Public perception of the potential risks posed by nanotechnology is very different in certain regions. In Asia, where there is a very positive perception of nanotechnology, some products have been marketed as being nano-enabled to justify charging a premium price. This has resulted in at least four Asian economies adopting state-operated, user-financed product testing schemes to verify nano-related marketing claims, such as the original “nanoMark” certification system in Taiwan.4

In contrast, the negative perception of nanotechnology in some other regions may result in questionable marketing decisions; for example, reducing the levels of zinc oxide nanoparticles included as the active ingredient in sunscreens. This is despite their use in sunscreens having been extensively and repeatedly assessed for safety by regulatory authorities around the world, leading to their being widely accepted as safe to use in sunscreens and lip products.5

Weighing the potential risks and benefits of using sunscreens with UV-filtering nanoparticles is an important issue for public health in Australia, which has the highest rate of skin cancer in the world as the result of excessive UV exposure. Some consumers are concerned about using these nano-sunscreens,6 despite their many advantages over conventional organic chemical UV filters, which can cause skin irritation and allergies, need to be re-applied more frequently, and are absorbed by the skin to a much greater extent (including some with potentially endocrine-disrupting activity). Zinc oxide nanoparticles are highly suitable for use in sunscreens as a physical broad spectrum UV filter because of their UV stability, non-irritating nature, hypo-allergenicity and visible transparency, while also having a greater UV-attenuating capacity than bulk material (particles larger than 100 nm in diameter) on a per weight basis.7

Concerns about nano-sunscreens began in 2008 with a report that nanoparticles in some could bleach the painted surfaces of coated steel.8 This is a completely different exposure situation to the actual use of nano-sunscreen by people; here they are formulated to remain on the skin’s surface, which is constantly shedding its outer layer of dead cells (the stratum corneum). Many studies have shown that metal oxide nanoparticles do not readily penetrate the stratum corneum of human skin, including a hallmark Australian investigation by Gulson and co-workers of sunscreens containing only a less abundant stable isotope of zinc that allowed precise tracking of the fate of sunscreen zinc.9 The researchers found that there was little difference between nanoparticle and bulk zinc oxide sunscreens in the amount of zinc absorbed into the body after repeated skin application during beach trials. The amount absorbed was also extremely small when compared with the normal levels of zinc required as an essential mineral for human nutrition, and the rate of skin absorption was much lower than that of the more commonly used chemical UV filters.9 Animal studies generally find much higher skin absorption of zinc from dermal application of zinc oxide sunscreens than do human studies, including the meticulous studies in hairless mice conducted by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) using both nanoparticle and bulk zinc oxide sunscreens that contained the less abundant stable zinc isotope.10 These researchers reported that the zinc absorbed from sunscreen was distributed throughout several major organs, but it did not alter their total zinc concentrations, and that overall zinc homeostasis was maintained.10

The other metal oxide UV filter is titanium dioxide. Two distinct crystalline forms have been used: the photo-active anatase form and the much less photo-active rutile form,7 which is preferable for sunscreen formulations. While these insoluble nanoparticles may penetrate deeper into the stratum corneum than zinc oxide, they are also widely accepted as being safe to use in non-sprayable sunscreens.11

Investigation of their direct effects on human skin and immune cells have shown that sunscreen nanoparticles of zinc oxide and rutile titanium dioxide are as well tolerated as zinc ions and conventional organic chemical UV filters in human cell test systems.12 Synchrotron X-ray fluorescence imaging has also shown that human immune cells break down zinc oxide nanoparticles similar to those in nano-sunscreens, indicating that immune cells can handle such particles.13 Cytotoxicity occurred only at very high concentrations of zinc oxide nanoparticles, after cellular uptake and intracellular dissolution,14 and further modification of the nanoparticle surface can be used to reduce both uptake by cells and consequent cytotoxicity.15

The ongoing debate about the safety of nanoparticles in sunscreens raised concerns that they may potentially increase free radical levels in human skin during co-exposure to UV light.6 On the contrary, we have seen that zinc oxide and rutile titanium dioxide nanoparticles directly reduce the quantity of damaging free radicals in human immune cells in vitro when they are co-exposed to the more penetrating UV-A wavelengths of sunlight.16 We also identified zinc-containing nanoparticles that form immediately when dissolved zinc ions are added to cell culture media and pure serum, which suggests that they may even play a role in natural zinc transport.17

The known benefits therefore clearly outweigh the risks of using nano-sunscreens. The important message to be communicated to the Australian public is that the danger of excessive UV light itself with respect to skin damage and cancer is far greater than the perceived risk posed by nano-sunscreens, which is not supported by the scientific literature. It is crucial that people do not stop using the most effective broad spectrum sunscreens as part of their sun protection measures.

Provenance: <p>Commissioned; externally peer reviewed.</p>

  • Paul FA Wright

  • RMIT University, Melbourne, VIC


Competing interests:

I have received research funding from the National Health and Medical Research Council (NHMRC), Safe Work Australia, the CSIRO Flagship collaboration fund top-up scholarship scheme, the Australian Synchrotron Foundation, and the Advanced Manufacturing Co-operative Research Centre (AMCRC) in cooperation with the commercial entities, the Victorian Centre for Advanced Materials Manufacturing (VCAMM), Baxter Laboratories, and Micronisers. I am affiliated with NanoSafe Australia and Asia Nano Safe research networks (as founding coordinator), the Australian Nanotechnology Network, the Standards Australia Technical Committee NT-001 (Nanotechnologies), the Safe Work Australia Nanotechnology OHS Measurement Reference Group, the Australian consortium for the OECD Working Party on Manufactured Nanomaterials (WPMN) and its Sponsorship Programme for the Testing of Manufactured Nanomaterials, and am a Fellow of the International Union of Pure and Applied Chemistry (IUPAC).

  • 1. Wright PFA, Jackson NRC. Safety of engineered nanomaterials and occupational health and safety issues for commercial scale production. In: Bawa R, Audette GF, Reese BE, editors. Handbook of clinical nanomedicine: law, business, regulation, safety, and risk. Singapore: Pan Stanford Publishing, 2016; pp 569-619.
  • 2. Wallace GG, Higgins MJ, Moulton SE, Wang C. Nanobionics: the impact of nanotechnology on implantable medical bionic devices. Nanoscale 2012; 4: 4327-4337.
  • 3. Scientific Committee on Emerging and Newly Identified Health Risks. Opinion on nanosilver: safety health and environmental effects and role in antimicrobial resistance (approved 10 June 2014). Luxembourg: European Commission, 2014. (accessed Sept 2015).
  • 4. Industrial Development Bureau, Ministry of Economic Affairs, Taiwan. nanoMark [website]. (accessed Sept 2015).
  • 5. Scientific Committee on Consumer Safety. Opinion on zinc oxide (nano form) (COLIPA S 76; SCCS/1489/12) (adopted 18 Sept 2012). Luxembourg: European Commission, 2012. (accessed Sept 2015).
  • 6. Berube DM. Rhetorical gamesmanship in the nano debates over sunscreens and nanoparticles. J Nanopart Res 2008; 10: 23-37.
  • 7. Egerton TA, Tooley IR. UV absorption and scattering properties of inorganic-based sunscreens. Int J Cosmet Sci 2012; 34: 117-122.
  • 8. Barker PJ, Branch A. The interaction of modern sunscreen formulations with surface coatings. Prog Org Coat 2008; 62: 313-320.
  • 9. Gulson B, McCall M, Korsch M, et al. Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol Sci 2010; 118: 140-149.
  • 10. Osmond-McLeod MJ, Oytam Y, Kirby JK, et al. Dermal absorption and short-term biological impact in hairless mice from sunscreens containing zinc oxide nano- or larger particles. Nanotoxicology 2014; 8 Suppl 1: 72-84.
  • 11. Scientific Committee on Consumer Safety. Opinion on titanium dioxide (nano form) (COLIPA S 75; SCCS/1516/13; adopted 22 April 2014). Luxembourg: European Commission, 2014. (accessed Sept 2015).
  • 12. Feltis BN, O’Keefe SJ, Harford AJ, et al. Independent cytotoxic and inflammatory responses to zinc oxide nanoparticles in human monocytes and macrophages. Nanotoxicology 2012; 6: 757-765.
  • 13. James SA, Feltis BN, deJonge MD, et al. Quantification of ZnO nanoparticle uptake, distribution and dissolution within individual human macrophages. ACS Nano 2013; 7: 10621-10635.
  • 14. Shen C, James SA, deJonge MD, et al. Relating cytotoxicity, zinc ions and reactive oxygen in ZnO nanoparticle exposed human immune cells. Toxicol Sci 2013; 136: 120-130.
  • 15. Luo M, Shen C, Feltis BN, et al. Reducing ZnO nanoparticle cytotoxicity by surface modification. Nanoscale 2014; 6: 5791-5798.
  • 16. Shen C, Turney TW, Piva TJ, et al. Comparison of UVA-induced ROS and sunscreen NP-generated ROS in human immune cells. Photochem Photobiol Sci 2014; 13: 781-788.
  • 17. Turney TW, Duriska MB, Jayaratne V, et al. Formation of zinc-containing nanoparticles from Zn2+ ions in cell culture media: implications for the nanotoxicology of ZnO. Chem Res Toxicol 2012; 25: 2057-2066.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

access_time 03:37, 9 June 2016
Louise Sales

The view that nano-ingredients in sunscreen are safe is not shared by the European Commission's Scientific Committee on Consumer Safety (SCCS). This body recently recommended that certain nano titanium dioxide ingredients not be used in sunscreen because they strongly react with sunlight to produce damaging free radicals. In fact, Paul Wright’s own research suggests that nanoparticles of anatase titanium dioxide increase the production of free radicals in human immune cells – yet this ingredient is still allowed in sunscreen in Australia.

The SCCS further recommends that nano titanium dioxide and nano zinc oxide not be used in powder or sprayable products because of the toxicity risk associated with inhalation. Meanwhile our regulators here have taken no action to remove these ingredients from spray on sunscreen.

In 2004, the UK Royal Society argued that nanomaterials pose different risks to larger particles of the same chemicals and need to be assessed for safety before being allowed in consumer products. It is a shocking indictment of our Government’s lack of precaution that over a decade later these substances have still not been assessed for safety, despite being used in a growing number of consumer products.

Competing Interests: No relevant disclosures

Ms Louise Sales
Friends of the Earth

Online responses are no longer available. Please refer to our instructions for authors page for more information.